Elaine Morrato
Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antipsychotic Agents | 15 | 2021 | 195 | 4.830 |
Why?
| Medicaid | 14 | 2022 | 433 | 2.490 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 9 | 2024 | 253 | 2.220 |
Why?
| Schizophrenia | 6 | 2021 | 432 | 1.820 |
Why?
| Blood Glucose | 11 | 2016 | 2102 | 1.400 |
Why?
| Lipids | 6 | 2016 | 628 | 1.350 |
Why?
| United States Food and Drug Administration | 10 | 2023 | 205 | 1.260 |
Why?
| Risk Management | 4 | 2020 | 90 | 1.210 |
Why?
| Practice Patterns, Physicians' | 12 | 2017 | 1271 | 1.160 |
Why?
| Developmental Disabilities | 2 | 2020 | 254 | 1.030 |
Why?
| United States | 42 | 2023 | 13906 | 0.980 |
Why?
| Risk Evaluation and Mitigation | 3 | 2024 | 3 | 0.970 |
Why?
| Prescription Drugs | 3 | 2022 | 112 | 0.910 |
Why?
| Diabetes Mellitus | 8 | 2021 | 1003 | 0.900 |
Why?
| Missouri | 8 | 2016 | 69 | 0.880 |
Why?
| Pharmaceutical Preparations | 3 | 2023 | 171 | 0.880 |
Why?
| Mental Disorders | 7 | 2015 | 1035 | 0.760 |
Why?
| Drug Prescriptions | 5 | 2016 | 248 | 0.750 |
Why?
| Risk Assessment | 8 | 2024 | 3260 | 0.750 |
Why?
| State Government | 1 | 2022 | 43 | 0.750 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2022 | 101 | 0.710 |
Why?
| Mass Screening | 4 | 2016 | 1192 | 0.700 |
Why?
| Insurance Coverage | 1 | 2022 | 220 | 0.670 |
Why?
| Depression, Postpartum | 1 | 2022 | 127 | 0.650 |
Why?
| Comparative Effectiveness Research | 3 | 2014 | 151 | 0.590 |
Why?
| Program Evaluation | 3 | 2023 | 877 | 0.590 |
Why?
| Antidepressive Agents, Second-Generation | 2 | 2009 | 43 | 0.580 |
Why?
| State Health Plans | 2 | 2016 | 32 | 0.580 |
Why?
| Stroke Rehabilitation | 1 | 2018 | 40 | 0.580 |
Why?
| Caregivers | 3 | 2022 | 807 | 0.570 |
Why?
| Humans | 70 | 2024 | 129687 | 0.570 |
Why?
| Periodontal Diseases | 2 | 2015 | 61 | 0.560 |
Why?
| Child Health Services | 1 | 2019 | 184 | 0.560 |
Why?
| Physician-Patient Relations | 2 | 2014 | 542 | 0.520 |
Why?
| Drug Utilization Review | 2 | 2014 | 57 | 0.510 |
Why?
| Community Mental Health Services | 2 | 2016 | 89 | 0.500 |
Why?
| Information Dissemination | 2 | 2015 | 206 | 0.500 |
Why?
| Community Mental Health Centers | 1 | 2015 | 13 | 0.490 |
Why?
| Paliperidone Palmitate | 1 | 2014 | 4 | 0.460 |
Why?
| Advisory Committees | 4 | 2012 | 216 | 0.450 |
Why?
| Risk | 2 | 2018 | 855 | 0.450 |
Why?
| Quality Control | 1 | 2014 | 162 | 0.440 |
Why?
| Dyslipidemias | 3 | 2010 | 177 | 0.440 |
Why?
| Bipolar Disorder | 1 | 2016 | 236 | 0.430 |
Why?
| Cohort Studies | 12 | 2020 | 5434 | 0.430 |
Why?
| Patient Care | 1 | 2014 | 108 | 0.420 |
Why?
| Health Services Research | 2 | 2015 | 392 | 0.410 |
Why?
| Physicians' Offices | 1 | 2012 | 17 | 0.400 |
Why?
| Universities | 1 | 2015 | 409 | 0.400 |
Why?
| Physician's Role | 1 | 2014 | 206 | 0.400 |
Why?
| Malpractice | 1 | 2012 | 39 | 0.390 |
Why?
| Primary Health Care | 3 | 2020 | 1687 | 0.390 |
Why?
| Injections | 3 | 2021 | 174 | 0.390 |
Why?
| Diabetes Mellitus, Type 2 | 5 | 2011 | 2443 | 0.390 |
Why?
| Anti-Obesity Agents | 1 | 2012 | 53 | 0.380 |
Why?
| Drug Approval | 1 | 2012 | 87 | 0.380 |
Why?
| Focus Groups | 1 | 2014 | 450 | 0.380 |
Why?
| Parents | 2 | 2019 | 1316 | 0.370 |
Why?
| Health Care Costs | 1 | 2014 | 367 | 0.360 |
Why?
| Drug Monitoring | 2 | 2010 | 215 | 0.360 |
Why?
| Patient Safety | 1 | 2014 | 289 | 0.360 |
Why?
| Female | 31 | 2022 | 68751 | 0.350 |
Why?
| Adolescent | 21 | 2016 | 20415 | 0.350 |
Why?
| Multivariate Analysis | 7 | 2015 | 1500 | 0.350 |
Why?
| Checklist | 2 | 2024 | 93 | 0.340 |
Why?
| Adult | 21 | 2022 | 35607 | 0.340 |
Why?
| Quality Improvement | 4 | 2020 | 1108 | 0.330 |
Why?
| Retrospective Studies | 15 | 2020 | 14525 | 0.330 |
Why?
| Hyperglycemia | 2 | 2011 | 327 | 0.330 |
Why?
| Managed Care Programs | 3 | 2009 | 132 | 0.320 |
Why?
| Hospitalization | 3 | 2014 | 2075 | 0.320 |
Why?
| Medication Adherence | 1 | 2014 | 561 | 0.320 |
Why?
| Polypharmacy | 2 | 2007 | 84 | 0.320 |
Why?
| Male | 29 | 2021 | 63691 | 0.320 |
Why?
| Hyperlipidemias | 1 | 2010 | 126 | 0.310 |
Why?
| Middle Aged | 18 | 2022 | 31165 | 0.310 |
Why?
| Databases, Factual | 8 | 2014 | 1269 | 0.310 |
Why?
| Risk Factors | 13 | 2015 | 9787 | 0.310 |
Why?
| Insurance Claim Review | 2 | 2021 | 64 | 0.300 |
Why?
| Administration, Oral | 3 | 2016 | 787 | 0.300 |
Why?
| Practice Guidelines as Topic | 2 | 2014 | 1506 | 0.300 |
Why?
| Cardiovascular Diseases | 4 | 2015 | 2008 | 0.300 |
Why?
| Emergency Medical Services | 1 | 2014 | 522 | 0.290 |
Why?
| Logistic Models | 5 | 2015 | 1988 | 0.280 |
Why?
| General Surgery | 2 | 2013 | 152 | 0.280 |
Why?
| Office Visits | 1 | 2007 | 87 | 0.280 |
Why?
| Neoplasms | 4 | 2023 | 2454 | 0.270 |
Why?
| Delayed-Action Preparations | 2 | 2021 | 174 | 0.270 |
Why?
| Pemoline | 1 | 2007 | 5 | 0.270 |
Why?
| Policy Making | 1 | 2007 | 88 | 0.270 |
Why?
| Metabolic Syndrome | 2 | 2011 | 340 | 0.260 |
Why?
| Data Collection | 3 | 2008 | 651 | 0.260 |
Why?
| Dementia | 2 | 2021 | 227 | 0.260 |
Why?
| Health Policy | 3 | 2007 | 354 | 0.250 |
Why?
| Cross-Sectional Studies | 5 | 2023 | 5083 | 0.250 |
Why?
| Guideline Adherence | 1 | 2010 | 527 | 0.250 |
Why?
| Physical Fitness | 1 | 2007 | 203 | 0.240 |
Why?
| Electronic Health Records | 1 | 2012 | 975 | 0.240 |
Why?
| California | 4 | 2010 | 400 | 0.230 |
Why?
| Child | 17 | 2022 | 20882 | 0.230 |
Why?
| Exercise | 2 | 2007 | 1933 | 0.230 |
Why?
| Behavioral Sciences | 1 | 2024 | 10 | 0.220 |
Why?
| Medicare | 2 | 2021 | 719 | 0.220 |
Why?
| Fee-for-Service Plans | 3 | 2021 | 88 | 0.220 |
Why?
| Drug Labeling | 3 | 2010 | 41 | 0.220 |
Why?
| Communication | 3 | 2022 | 846 | 0.220 |
Why?
| Diabetes Complications | 4 | 2011 | 224 | 0.210 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 2015 | 3629 | 0.210 |
Why?
| Evidence-Based Medicine | 1 | 2007 | 713 | 0.210 |
Why?
| Specialties, Surgical | 3 | 2013 | 74 | 0.210 |
Why?
| Obesity | 3 | 2012 | 2885 | 0.210 |
Why?
| Young Adult | 9 | 2016 | 12457 | 0.210 |
Why?
| Small-Area Analysis | 2 | 2014 | 9 | 0.200 |
Why?
| Aged, 80 and over | 8 | 2018 | 7064 | 0.200 |
Why?
| Infant | 5 | 2020 | 8987 | 0.200 |
Why?
| Age Factors | 4 | 2019 | 3153 | 0.180 |
Why?
| Diffusion of Innovation | 2 | 2013 | 97 | 0.180 |
Why?
| Treatment Outcome | 5 | 2021 | 10221 | 0.180 |
Why?
| Aged | 13 | 2021 | 22101 | 0.180 |
Why?
| Stakeholder Participation | 1 | 2022 | 76 | 0.180 |
Why?
| Mental Status and Dementia Tests | 1 | 2021 | 23 | 0.180 |
Why?
| Child, Preschool | 7 | 2019 | 10487 | 0.170 |
Why?
| Public Health | 3 | 2023 | 487 | 0.170 |
Why?
| Spinal Fusion | 2 | 2013 | 231 | 0.160 |
Why?
| Oregon | 2 | 2010 | 70 | 0.160 |
Why?
| Information Storage and Retrieval | 1 | 2020 | 108 | 0.160 |
Why?
| Delivery of Health Care | 2 | 2023 | 900 | 0.150 |
Why?
| Surgical Procedures, Operative | 2 | 2013 | 243 | 0.150 |
Why?
| Mentors | 2 | 2023 | 177 | 0.150 |
Why?
| Nootropic Agents | 1 | 2018 | 29 | 0.150 |
Why?
| Professional-Family Relations | 1 | 2019 | 142 | 0.150 |
Why?
| Medicare Part D | 1 | 2018 | 26 | 0.150 |
Why?
| Pediatrics | 4 | 2017 | 1056 | 0.140 |
Why?
| Recurrence | 1 | 2021 | 1012 | 0.140 |
Why?
| Social Networking | 1 | 2018 | 33 | 0.140 |
Why?
| Severity of Illness Index | 2 | 2019 | 2739 | 0.140 |
Why?
| Health Services Accessibility | 2 | 2022 | 903 | 0.140 |
Why?
| Time-to-Treatment | 1 | 2019 | 179 | 0.140 |
Why?
| Curriculum | 2 | 2015 | 925 | 0.140 |
Why?
| Drug and Narcotic Control | 2 | 2007 | 28 | 0.130 |
Why?
| Odds Ratio | 3 | 2015 | 1021 | 0.130 |
Why?
| Health Priorities | 1 | 2017 | 34 | 0.130 |
Why?
| Preventive Health Services | 1 | 2018 | 145 | 0.130 |
Why?
| Monitoring, Physiologic | 2 | 2009 | 266 | 0.130 |
Why?
| Cancer Survivors | 1 | 2021 | 257 | 0.130 |
Why?
| Suicide | 3 | 2007 | 616 | 0.130 |
Why?
| Evidence-Based Practice | 1 | 2018 | 212 | 0.130 |
Why?
| Indians, North American | 1 | 2021 | 601 | 0.120 |
Why?
| Urban Population | 1 | 2019 | 443 | 0.120 |
Why?
| Birth Weight | 1 | 2019 | 505 | 0.120 |
Why?
| Societies, Medical | 2 | 2010 | 744 | 0.120 |
Why?
| Mental Health | 3 | 2011 | 691 | 0.120 |
Why?
| Hospitals, Pediatric | 3 | 2013 | 513 | 0.120 |
Why?
| Case Management | 1 | 2015 | 64 | 0.120 |
Why?
| Patient-Centered Care | 3 | 2018 | 508 | 0.120 |
Why?
| Poverty | 1 | 2019 | 499 | 0.120 |
Why?
| Time Factors | 3 | 2014 | 6545 | 0.120 |
Why?
| Spatial Analysis | 1 | 2014 | 21 | 0.110 |
Why?
| Research Support as Topic | 1 | 2015 | 112 | 0.110 |
Why?
| Referral and Consultation | 1 | 2020 | 735 | 0.110 |
Why?
| Analgesics, Opioid | 1 | 2022 | 913 | 0.110 |
Why?
| Hospitals, General | 1 | 2013 | 22 | 0.110 |
Why?
| Prevalence | 4 | 2008 | 2563 | 0.110 |
Why?
| Bias | 1 | 2014 | 197 | 0.100 |
Why?
| Home Nursing | 1 | 2013 | 26 | 0.100 |
Why?
| Insurance, Liability | 1 | 2012 | 6 | 0.100 |
Why?
| Organizational Objectives | 1 | 2013 | 73 | 0.100 |
Why?
| Socioeconomic Factors | 3 | 2018 | 1214 | 0.100 |
Why?
| Patient Care Team | 1 | 2018 | 601 | 0.100 |
Why?
| Organizational Case Studies | 1 | 2012 | 74 | 0.100 |
Why?
| Liability, Legal | 1 | 2012 | 41 | 0.100 |
Why?
| Classification | 1 | 2012 | 19 | 0.100 |
Why?
| Healthcare Disparities | 1 | 2018 | 580 | 0.100 |
Why?
| Attitude of Health Personnel | 1 | 2019 | 1103 | 0.100 |
Why?
| Oral Hygiene | 1 | 2011 | 16 | 0.090 |
Why?
| Mentally Ill Persons | 1 | 2011 | 13 | 0.090 |
Why?
| Disease Management | 1 | 2015 | 588 | 0.090 |
Why?
| Models, Organizational | 1 | 2012 | 145 | 0.090 |
Why?
| Fundoplication | 1 | 2011 | 54 | 0.090 |
Why?
| Sex Factors | 2 | 2007 | 1973 | 0.090 |
Why?
| Laparotomy | 1 | 2011 | 106 | 0.090 |
Why?
| Biomedical Research | 1 | 2017 | 640 | 0.090 |
Why?
| Educational Status | 3 | 2011 | 473 | 0.090 |
Why?
| Interprofessional Relations | 1 | 2013 | 279 | 0.080 |
Why?
| Matched-Pair Analysis | 1 | 2010 | 40 | 0.080 |
Why?
| Triglycerides | 2 | 2011 | 528 | 0.080 |
Why?
| Interviews as Topic | 1 | 2013 | 709 | 0.080 |
Why?
| Perception | 1 | 2012 | 347 | 0.080 |
Why?
| Specialization | 2 | 2007 | 145 | 0.080 |
Why?
| Body Mass Index | 3 | 2007 | 2274 | 0.080 |
Why?
| Benchmarking | 1 | 2011 | 176 | 0.080 |
Why?
| Pregnancy | 1 | 2022 | 6412 | 0.080 |
Why?
| Consensus Development Conferences as Topic | 1 | 2009 | 27 | 0.080 |
Why?
| Medicine | 2 | 2007 | 119 | 0.080 |
Why?
| Patient Satisfaction | 1 | 2013 | 636 | 0.080 |
Why?
| Glucose Tolerance Test | 1 | 2010 | 355 | 0.070 |
Why?
| Tennessee | 1 | 2008 | 43 | 0.070 |
Why?
| Comorbidity | 2 | 2010 | 1551 | 0.070 |
Why?
| Medical Audit | 1 | 2008 | 74 | 0.070 |
Why?
| Surgical Wound Infection | 1 | 2011 | 282 | 0.070 |
Why?
| Utah | 1 | 2008 | 64 | 0.070 |
Why?
| Legislation, Medical | 1 | 2007 | 11 | 0.070 |
Why?
| State Medicine | 1 | 2007 | 19 | 0.070 |
Why?
| Risk Adjustment | 1 | 2008 | 79 | 0.070 |
Why?
| Psychotic Disorders | 1 | 2010 | 151 | 0.070 |
Why?
| Health Surveys | 2 | 2007 | 494 | 0.070 |
Why?
| Evaluation Studies as Topic | 1 | 2007 | 176 | 0.070 |
Why?
| Appointments and Schedules | 1 | 2007 | 85 | 0.070 |
Why?
| Clozapine | 1 | 2007 | 21 | 0.070 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
| United Kingdom | 1 | 2007 | 258 | 0.070 |
Why?
| Cholesterol | 1 | 2009 | 412 | 0.070 |
Why?
| Australia | 1 | 2007 | 243 | 0.070 |
Why?
| Laparoscopy | 1 | 2011 | 447 | 0.070 |
Why?
| Product Surveillance, Postmarketing | 1 | 2007 | 62 | 0.070 |
Why?
| Quality Assurance, Health Care | 1 | 2008 | 318 | 0.060 |
Why?
| Follow-Up Studies | 3 | 2011 | 4892 | 0.060 |
Why?
| Immunization Programs | 1 | 2007 | 214 | 0.060 |
Why?
| Waiting Lists | 1 | 2007 | 238 | 0.060 |
Why?
| Decision Making | 1 | 2012 | 863 | 0.060 |
Why?
| Central Nervous System Stimulants | 1 | 2007 | 154 | 0.060 |
Why?
| Depressive Disorder | 1 | 2007 | 367 | 0.060 |
Why?
| Drug Therapy, Combination | 1 | 2007 | 1042 | 0.050 |
Why?
| Coronary Disease | 1 | 2006 | 385 | 0.050 |
Why?
| Proportional Hazards Models | 1 | 2007 | 1199 | 0.050 |
Why?
| Depressive Disorder, Major | 1 | 2007 | 345 | 0.050 |
Why?
| Quality of Health Care | 1 | 2008 | 609 | 0.050 |
Why?
| Incidence | 1 | 2010 | 2644 | 0.050 |
Why?
| Diabetic Angiopathies | 1 | 2005 | 261 | 0.050 |
Why?
| Colorado | 1 | 2012 | 4405 | 0.050 |
Why?
| Counseling | 1 | 2006 | 386 | 0.050 |
Why?
| Guidelines as Topic | 1 | 2024 | 264 | 0.050 |
Why?
| Alaska | 1 | 2021 | 82 | 0.050 |
Why?
| South Carolina | 2 | 2011 | 40 | 0.050 |
Why?
| Patient Education as Topic | 1 | 2006 | 743 | 0.040 |
Why?
| Postoperative Complications | 2 | 2011 | 2470 | 0.040 |
Why?
| Survivorship | 1 | 2021 | 47 | 0.040 |
Why?
| Substance-Related Disorders | 1 | 2009 | 1022 | 0.040 |
Why?
| Medical Oncology | 1 | 2022 | 268 | 0.040 |
Why?
| Europe | 1 | 2020 | 363 | 0.040 |
Why?
| Health Personnel | 1 | 2024 | 656 | 0.040 |
Why?
| Research Design | 1 | 2024 | 1045 | 0.040 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 5427 | 0.040 |
Why?
| Students | 1 | 2023 | 582 | 0.040 |
Why?
| Independent Living | 1 | 2018 | 97 | 0.030 |
Why?
| Pharmacoepidemiology | 1 | 2015 | 20 | 0.030 |
Why?
| Health Promotion | 1 | 2022 | 718 | 0.030 |
Why?
| Residence Characteristics | 1 | 2018 | 332 | 0.030 |
Why?
| Global Health | 1 | 2015 | 328 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 569 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2012 | 25 | 0.020 |
Why?
| Gingival Hemorrhage | 1 | 2011 | 2 | 0.020 |
Why?
| Radiography, Bitewing | 1 | 2011 | 2 | 0.020 |
Why?
| Dental Devices, Home Care | 1 | 2011 | 4 | 0.020 |
Why?
| Toothbrushing | 1 | 2011 | 6 | 0.020 |
Why?
| Alveolar Bone Loss | 1 | 2011 | 9 | 0.020 |
Why?
| Periodontal Attachment Loss | 1 | 2011 | 10 | 0.020 |
Why?
| Mouthwashes | 1 | 2011 | 14 | 0.020 |
Why?
| Xerostomia | 1 | 2011 | 17 | 0.020 |
Why?
| Dental Care | 1 | 2011 | 26 | 0.020 |
Why?
| Accreditation | 1 | 2012 | 80 | 0.020 |
Why?
| Chronic Disease | 1 | 2018 | 1723 | 0.020 |
Why?
| Certification | 1 | 2012 | 95 | 0.020 |
Why?
| Income | 1 | 2011 | 188 | 0.020 |
Why?
| Confidence Intervals | 1 | 2011 | 317 | 0.020 |
Why?
| Community Networks | 1 | 2011 | 56 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 421 | 0.020 |
Why?
| C-Peptide | 1 | 2011 | 163 | 0.020 |
Why?
| Infant, Newborn | 2 | 2013 | 5759 | 0.020 |
Why?
| Health Care Surveys | 1 | 2011 | 558 | 0.020 |
Why?
| Pain Measurement | 1 | 2011 | 505 | 0.020 |
Why?
| Regression Analysis | 1 | 2011 | 997 | 0.020 |
Why?
| Statistics as Topic | 1 | 2009 | 306 | 0.020 |
Why?
| Population Surveillance | 1 | 2011 | 439 | 0.020 |
Why?
| Education, Medical, Graduate | 1 | 2012 | 441 | 0.020 |
Why?
| Patient Discharge | 1 | 2013 | 856 | 0.020 |
Why?
| National Health Programs | 1 | 2006 | 17 | 0.020 |
Why?
| Mental Health Services | 1 | 2011 | 404 | 0.020 |
Why?
| Drug Utilization | 1 | 2007 | 171 | 0.020 |
Why?
| Qualitative Research | 1 | 2013 | 1235 | 0.020 |
Why?
| Health Behavior | 1 | 2011 | 743 | 0.020 |
Why?
| Pilot Projects | 1 | 2011 | 1594 | 0.020 |
Why?
| Length of Stay | 1 | 2011 | 1127 | 0.020 |
Why?
| Physicians, Family | 1 | 2007 | 206 | 0.020 |
Why?
| Quality Indicators, Health Care | 1 | 2008 | 298 | 0.020 |
Why?
| Survival Analysis | 1 | 2008 | 1270 | 0.010 |
Why?
| Seasons | 1 | 2007 | 493 | 0.010 |
Why?
| Clinical Competence | 1 | 2012 | 1018 | 0.010 |
Why?
| Psychiatry | 1 | 2007 | 179 | 0.010 |
Why?
| Survival Rate | 1 | 2008 | 1872 | 0.010 |
Why?
| Life Style | 1 | 2005 | 462 | 0.010 |
Why?
| Motor Activity | 1 | 2005 | 684 | 0.010 |
Why?
| Prospective Studies | 1 | 2011 | 7145 | 0.010 |
Why?
|
|
Morrato's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|